Marshall Wace’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-100,106
Closed -$1.6M 2806
2024
Q3
$1.6M Buy
100,106
+34,163
+52% +$546K ﹤0.01% 1335
2024
Q2
$940K Buy
65,943
+14,220
+27% +$203K ﹤0.01% 1559
2024
Q1
$733K Buy
+51,723
New +$733K ﹤0.01% 1556
2023
Q3
Sell
-11,312
Closed -$171K 2323
2023
Q2
$171K Sell
11,312
-6,015
-35% -$91.1K ﹤0.01% 1834
2023
Q1
$251K Buy
+17,327
New +$251K ﹤0.01% 1867